Flavobacterial peritonitis in patients treated by peritoneal dialysis.
Korzets
Z
Z
Department of Nephrology, Meir Hospital, Kfar Saba, Israel.
Maayan
M C
MC
Bernheim
J
J
D004927:Escherichia coli Infections / Q000209:etiology; D005417:Flavobacterium / Q000302:isolation & purification*; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D015366:Pefloxacin / Q000627:therapeutic use; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy / Q000382:microbiology*; D013203:Staphylococcal Infections / Q000209:etiology; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D015366:Pefloxacin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination